{"url_path":"/sec/bkyi/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-021335-index.html","accession_number":"0001437749-26-021335","cik":"0001019034","ticker":"BKYI","issuer_name":"BIO KEY INTERNATIONAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-021335-index.html","primary_entity_key":"0001019034","primary_entity_name":"BIO KEY INTERNATIONAL INC"},"word_count":794,"has_tables":true,"body_markdown":"bkyi20260331_10q.htm\n\n0001019034\nBIO KEY INTERNATIONAL INC\nfalse\n--12-31\nQ1\n2026\n\n170,000,000\n170,000,000\n1,085,360\n1,085,360\n1,085,360\n1,085,360\n0.0001\n0.0001\n1,956,707\n0\n3\n3\n0\n0\n5\n2\n2\n2\n2\n0\n0\n0\n1\nfalse\nfalse\nfalse\nfalse\nEMESA – Europe, Middle East, South America\n\n00010190342026-01-012026-03-31\nxbrli:shares\n00010190342026-06-19\nthunderdome:item\niso4217:USD\n00010190342026-03-31\n00010190342025-12-31\n0001019034bkyi:SeniorSecuredPromissoryNoteMember2026-03-31\n0001019034bkyi:SeniorSecuredPromissoryNoteMember2025-12-31\n0001019034bkyi:GovernmentLoanMember2026-03-31\n0001019034bkyi:GovernmentLoanMember2025-12-31\niso4217:USDxbrli:shares\n0001019034us-gaap:ServiceMember2026-01-012026-03-31\n0001019034us-gaap:ServiceMember2025-01-012025-03-31\n0001019034us-gaap:LicenseMember2026-01-012026-03-31\n0001019034us-gaap:LicenseMember2025-01-012025-03-31\n0001019034bkyi:HardwareMember2026-01-012026-03-31\n0001019034bkyi:HardwareMember2025-01-012025-03-31\n00010190342025-01-012025-03-31\n0001019034bkyi:HardwareReserveMember2026-01-012026-03-31\n0001019034bkyi:HardwareReserveMember2025-01-012025-03-31\n0001019034us-gaap:CommonStockMember2025-12-31\n0001019034us-gaap:AdditionalPaidInCapitalMember2025-12-31\n0001019034us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-31\n0001019034us-gaap:RetainedEarningsMember2025-12-31\n0001019034us-gaap:CommonStockMember2026-01-012026-03-31\n0001019034us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31\n0001019034us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-31\n0001019034us-gaap:RetainedEarningsMember2026-01-012026-03-31\n0001019034us-gaap:CommonStockMember2026-03-31\n0001019034us-gaap:AdditionalPaidInCapitalMember2026-03-31\n0001019034us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-31\n0001019034us-gaap:RetainedEarningsMember2026-03-31\n0001019034us-gaap:CommonStockMember2024-12-31\n0001019034us-gaap:AdditionalPaidInCapitalMember2024-12-31\n0001019034us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-31\n0001019034us-gaap:RetainedEarningsMember2024-12-31\n00010190342024-12-31\n0001019034us-gaap:CommonStockMember2025-01-012025-03-31\n0001019034us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31\n0001019034us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-31\n0001019034us-gaap:RetainedEarningsMember2025-01-012025-03-31\n0001019034us-gaap:CommonStockMember2025-03-31\n0001019034us-gaap:AdditionalPaidInCapitalMember2025-03-31\n0001019034us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-31\n0001019034us-gaap:RetainedEarningsMember2025-03-31\n00010190342025-03-31\nxbrli:pure\n0001019034bkyi:ReverseStockSplitMemberus-gaap:SubsequentEventMember2026-04-302026-04-30\n0001019034us-gaap:ServiceMembersrt:NorthAmericaMember2026-01-012026-03-31\n0001019034us-gaap:ServiceMembersrt:AfricaMember2026-01-012026-03-31\n0001019034us-gaap:ServiceMemberbkyi:EMESAMember2026-01-012026-03-31\n0001019034us-gaap:ServiceMembersrt:AsiaMember2026-01-012026-03-31\n0001019034us-gaap:LicenseMembersrt:NorthAmericaMember2026-01-012026-03-31\n0001019034us-gaap:LicenseMembersrt:AfricaMember2026-01-012026-03-31\n0001019034us-gaap:LicenseMemberbkyi:EMESAMember2026-01-012026-03-31\n0001019034us-gaap:LicenseMembersrt:AsiaMember2026-01-012026-03-31\n0001019034bkyi:HardwareMembersrt:NorthAmericaMember2026-01-012026-03-31\n0001019034bkyi:HardwareMembersrt:AfricaMember2026-01-012026-03-31\n0001019034bkyi:HardwareMemberbkyi:EMESAMember2026-01-012026-03-31\n0001019034bkyi:HardwareMembersrt:AsiaMember2026-01-012026-03-31\n0001019034srt:NorthAmericaMember2026-01-012026-03-31\n0001019034srt:AfricaMember2026-01-012026-03-31\n0001019034bkyi:EMESAMember2026-01-012026-03-31\n0001019034srt:AsiaMember2026-01-012026-03-31\n0001019034us-gaap:ServiceMembersrt:NorthAmericaMember2025-01-012025-03-31\n0001019034us-gaap:ServiceMembersrt:AfricaMember2025-01-012025-03-31\n0001019034us-gaap:ServiceMemberbkyi:EMESAMember2025-01-012025-03-31\n0001019034us-gaap:ServiceMembersrt:AsiaMember2025-01-012025-03-31\n0001019034us-gaap:LicenseMembersrt:NorthAmericaMember2025-01-012025-03-31\n0001019034us-gaap:LicenseMembersrt:AfricaMember2025-01-012025-03-31\n0001019034us-gaap:LicenseMemberbkyi:EMESAMember2025-01-012025-03-31\n0001019034us-gaap:LicenseMembersrt:AsiaMember2025-01-012025-03-31\n0001019034bkyi:HardwareMembersrt:NorthAmericaMember2025-01-012025-03-31\n0001019034bkyi:HardwareMembersrt:AfricaMember2025-01-012025-03-31\n0001019034bkyi:HardwareMemberbkyi:EMESAMember2025-01-012025-03-31\n0001019034bkyi:HardwareMembersrt:AsiaMember2025-01-012025-03-31\n0001019034srt:NorthAmericaMember2025-01-012025-03-31\n0001019034srt:AfricaMember2025-01-012025-03-31\n0001019034bkyi:EMESAMember2025-01-012025-03-31\n0001019034srt:AsiaMember2025-01-012025-03-31\nutr:Y\n0001019034srt:MinimumMember2026-03-31\n0001019034srt:MaximumMember2026-03-31\n0001019034us-gaap:SellingGeneralAndAdministrativeExpense2026-01-012026-03-31\n0001019034us-gaap:SellingGeneralAndAdministrativeExpense2025-01-012025-03-31\n0001019034us-gaap:ResearchAndDevelopmentExpense2026-01-012026-03-31\n0001019034us-gaap:ResearchAndDevelopmentExpense2025-01-012025-03-31\n0001019034bkyi:BoumarangIncMember2024-11-27\n0001019034bkyi:BiokeyInternationalMemberbkyi:BoumarangIncMember2024-11-272024-11-27\n0001019034bkyi:WavedronePlatformFromShoreHouseIvfMemberbkyi:BoumarangIncMember2025-04-012025-04-30\n0001019034bkyi:MeasurementInputImpairmentOfInvestmentsMemberbkyi:BoumarangIncMember2025-12-31\n00010190342025-01-012025-12-31\n0001019034bkyi:The2024NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2024-06-24\n0001019034bkyi:The2024NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2024-06-242024-06-24\n0001019034bkyi:The2024NoteMemberbkyi:SeniorSecuredPromissoryNoteMembersrt:MaximumMember2024-06-24\n0001019034bkyi:WarrantInducementAgreementMember2024-07-012024-09-30\n0001019034bkyi:The2024NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2024-10-012024-10-01\n0001019034bkyi:The2024NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2025-09-30\n0001019034bkyi:PromissoryNote1Member2025-10-27\n0001019034bkyi:PromissoryNote2Member2025-10-27\n0001019034bkyi:The2024NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2025-10-272025-10-27\n0001019034bkyi:ConversionOfPartitionedNotesToCommonStockMember2025-10-272025-10-27\n0001019034bkyi:The2025NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2025-09-30\n0001019034bkyi:The2025NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2025-09-302025-09-30\n0001019034bkyi:The2025NoteMemberbkyi:SeniorSecuredPromissoryNoteMembersrt:MaximumMember2025-09-30\n0001019034bkyi:The2025NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2025-10-272025-10-27\n0001019034bkyi:The2025NoteMemberbkyi:SeniorSecuredPromissoryNoteMember2026-03-31\n0001019034us-gaap:EmployeeStockOptionMemberbkyi:ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember2026-01-012026-03-31\n0001019034us-gaap:EmployeeStockOptionMemberbkyi:ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember2025-01-012025-03-31\n0001019034us-gaap:WarrantMemberbkyi:ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember2026-01-012026-03-31\n0001019034us-gaap:WarrantMemberbkyi:ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember2025-01-012025-03-31\n0001019034bkyi:ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember2026-01-012026-03-31\n0001019034bkyi:ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember2025-01-012025-03-31\n0001019034bkyi:EmployeeStockPurchasePlanMember2021-06-18\n0001019034bkyi:EmployeeStockPurchasePlanMember2021-06-182021-06-18\n0001019034bkyi:EmployeeStockPurchasePlanMember2025-08-082025-08-08\n0001019034bkyi:EmployeeStockPurchasePlanMember2026-01-012026-03-31\n0001019034bkyi:EmployeeStockPurchasePlanMember2025-01-012025-03-31\n0001019034us-gaap:RestrictedStockMember2026-01-012026-03-31\n0001019034us-gaap:RestrictedStockMember2025-01-012025-03-31\n0001019034srt:DirectorMember2026-01-012026-03-31\n0001019034srt:DirectorMember2025-01-012025-03-31\n0001019034bkyi:ExistingWarrantsMember2025-10-272025-10-27\n0001019034bkyi:ExistingWarrantsMember2025-01-15\n0001019034bkyi:ExistingWarrantsMember2025-10-27\n0001019034bkyi:NewWarrantsMember2025-10-27\n0001019034bkyi:OutstandingWarrantsMember2025-01-152025-01-15\n0001019034bkyi:OutstandingWarrantsMember2025-01-15\n0001019034bkyi:OutstandingWarrantsMember2024-09-12\n0001019034bkyi:OutstandingWarrantsMember2024-09-122024-09-12\n0001019034bkyi:ExchangeAgreementConversionsIntoCommonStockMember2025-01-012025-03-31\n0001019034us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-03-31\n0001019034us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberbkyi:TwoCustomersMember2026-01-012026-03-31\n0001019034us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-31\n0001019034us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberbkyi:TwoCustomersMember2025-01-012025-03-31\n0001019034us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-03-31\n0001019034us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberbkyi:TwoCustomersMember2026-01-012026-03-31\n0001019034us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-31\n0001019034us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberbkyi:TwoCustomersMember2025-01-012025-12-31\n0001019034bkyi:UnitedStatesHongKongAndNigeriaMember2026-01-012026-03-31\n0001019034bkyi:UnitedStatesHongKongAndNigeriaMember2025-01-012025-03-31\n0001019034country:ES2026-01-012026-03-31\n\n \n\n \n\n[Table of Contents](#toc)\n\n \n\n**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n \n\n**FORM** **10-Q**\n\n \n\n \n☒\n\n**QUARTERLY REPORT PURSUANT TO SECTION** **13 OR 15(D)** **OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the quarterly period ended March 31, 2026**\n\n**or**\n\n \n☐\n\n**TRANSITION REPORT PURSUANT TO SECTION** **13 OR 15(D)** **OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the Transition Period from**            **to**\n\n \n\n**Commission file number 1-13463**\n\n \n\n**BIO-KEY INTERNATIONAL, INC.**\n\n(Exact Name of Registrant as Specified in Its Charter)\n\n \n\n**Delaware**\n\n**41-1741861**\n\n(State or Other Jurisdiction of Incorporation of Organization)\n\n(IRS Employer Identification Number)\n\n \n\n**101 CRAWFORDS CORNER ROAD, SUITE 4116, HOLMDEL, NJ 07733**\n\n \n\n(Address of Principal Executive Offices) (Zip Code)\n\n \n\n**(732) 359-1100**\n\n(Registrant’s telephone number, including area code)\n\n \n\nSecurities registered pursuance to Section 12(b) of the Act:\n\n \n\n**Title of each class**\n\n**Trading Symbol**\n\n**Name of each exchange on which**\n\n**registered**\n\nCommon Stock, par value $0.0001 per share\n\nBKYI\n\nNasdaq Capital Market\n\n \n\nIndicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒   No  ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒   No  ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐\n\n \nAccelerated filer ☐\n\n  \n\nNon-accelerated filer ☒\n\n \nSmaller Reporting Company ☒\n\n  \n\n \n \nEmerging growth company  ☐\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined by rule 12b-2 of the Exchange Act)  Yes  ☐  No  ☒\n\n \n\nNumber of shares of Common Stock, $.0001 par value per share, outstanding as of June 19, 2026, is 1,085,360 (as adjusted to reflect our 1-for-10 reverse stock split, which was effective April 30, 2026).\n\n \n\n \n\n[Table of Contents](#toc)\n\n \n\n \n\n**BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES**\n\n \n\n**INDEX**\n\n \n\n[PART I. FINANCIAL INFORMATION](#Part1)\n\n[3](#Part1)\n\n \n \n\n[Item 1— Financial Statements:](#bs)\n\n \n\n[Condensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025](#bs)\n\n[3](#bs)\n\n[Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2026 and 2025 (Unaudited)](#income)\n\n[4](#income)\n\n[Condensed Consolidated Statements of Stockholders’ Equity for the three nine months ended March 31, 2026 and 2025 ](#equity)[(Unaudited)](#income)\n\n[5](#equity)\n\n[Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (Unaudited)](#cashflows)\n\n[7](#cashflows)\n\n[Notes to Condensed Consolidated Financial Statements](#notes)\n\n[9](#notes)\n\n \n \n\n[Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations.](#mda)\n\n[17](#mda)\n\n \n \n\n[Item 3—Quantitative and Qualitative Disclosures about Market Risk.](#quantandqual)\n[22](#quantandqual)\n\n \n \n\n[Item 4—Controls and Procedures.](#controls)\n\n[22](#controls)\n\n \n \n\n[PART II. OTHER INFORMATION](#part2)\n\n[23](#part2)\n\n \n \n\n[Item 1—Legal Proceedings.](#legalpro)\n[23](#legalpro)\n\n \n \n\n[Item 1A—Risk Factors.](#item1a)\n[23](#item1a)\n\n \n \n\n[Item 2—Unregistered Sales of Equity Securities and Use of Proceeds.](#unregsales)\n[23](#unregsales)\n\n \n \n\n[Item 3—Defaults upon Senior Securities.](#defaults)\n[23](#defaults)\n\n \n \n\n[Item 4—Mine Safety Disclosures.](#mine)\n[23](#mine)\n\n \n \n\n[Item 5—Other Information.](#otherinfo)\n[23](#otherinfo)\n\n \n \n\n[Item 6—Exhibits.](#Exhibits)\n\n[23](#Exhibits)\n\n \n \n\n[Signatures](#Signatures)\n\n[24](#Signatures)\n\n \n\n \n\n[Table of Contents](#toc)\n\n \n\n \n\n \n\n**PART** **I -- FINANCIAL INFORMATION**"}